These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 29780446)
1. Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(iii) complexes. Cao JJ; Tan CP; Chen MH; Wu N; Yao DY; Liu XG; Ji LN; Mao ZW Chem Sci; 2017 Jan; 8(1):631-640. PubMed ID: 29780446 [TBL] [Abstract][Full Text] [Related]
2. Simultaneously Inducing and Tracking Cancer Cell Metabolism Repression by Mitochondria-Immobilized Rhenium(I) Complex. Yang J; Zhao JX; Cao Q; Hao L; Zhou D; Gan Z; Ji LN; Mao ZW ACS Appl Mater Interfaces; 2017 Apr; 9(16):13900-13912. PubMed ID: 28368110 [TBL] [Abstract][Full Text] [Related]
3. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties. Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583 [TBL] [Abstract][Full Text] [Related]
4. Cyclometalated iridium(iii) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agents. He L; Li Y; Tan CP; Ye RR; Chen MH; Cao JJ; Ji LN; Mao ZW Chem Sci; 2015 Oct; 6(10):5409-5418. PubMed ID: 29861886 [TBL] [Abstract][Full Text] [Related]
5. Coumarin-appended phosphorescent cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents. Ye RR; Tan CP; Ji LN; Mao ZW Dalton Trans; 2016 Aug; 45(33):13042-51. PubMed ID: 27139504 [TBL] [Abstract][Full Text] [Related]
6. Cyclometalated iridium(iii) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo. He L; Wang KN; Zheng Y; Cao JJ; Zhang MF; Tan CP; Ji LN; Mao ZW Dalton Trans; 2018 May; 47(20):6942-6953. PubMed ID: 29721561 [TBL] [Abstract][Full Text] [Related]
7. Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents. Li Y; Liu B; Lu XR; Li MF; Ji LN; Mao ZW Dalton Trans; 2017 Aug; 46(34):11363-11371. PubMed ID: 28812748 [TBL] [Abstract][Full Text] [Related]
8. Cyclometalated iridium(III) dithioformic acid complexes as mitochondria-targeted imaging and anticancer agents. Wu Y; Liu J; Shao M; Zhang P; Song S; Yang G; Liu X; Liu Z J Inorg Biochem; 2022 Aug; 233():111855. PubMed ID: 35576884 [TBL] [Abstract][Full Text] [Related]
9. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis. Chen BB; Pan NL; Liao JX; Huang MY; Jiang DC; Wang JJ; Qiu HJ; Chen JX; Li L; Sun J J Inorg Biochem; 2021 Jun; 219():111450. PubMed ID: 33826973 [TBL] [Abstract][Full Text] [Related]
10. Valproic Acid-Functionalized Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents. Ye RR; Cao JJ; Tan CP; Ji LN; Mao ZW Chemistry; 2017 Oct; 23(60):15166-15176. PubMed ID: 28833658 [TBL] [Abstract][Full Text] [Related]
11. Anticancer Cyclometalated Iridium(III) Complexes with Planar Ligands: Mitochondrial DNA Damage and Metabolism Disturbance. Cao JJ; Zheng Y; Wu XW; Tan CP; Chen MH; Wu N; Ji LN; Mao ZW J Med Chem; 2019 Apr; 62(7):3311-3322. PubMed ID: 30816710 [TBL] [Abstract][Full Text] [Related]
12. Light-Up Mitophagy in Live Cells with Dual-Functional Theranostic Phosphorescent Iridium(III) Complexes. Chen MH; Wang FX; Cao JJ; Tan CP; Ji LN; Mao ZW ACS Appl Mater Interfaces; 2017 Apr; 9(15):13304-13314. PubMed ID: 28345337 [TBL] [Abstract][Full Text] [Related]
13. Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents. Wang FX; Chen MH; Hu XY; Ye RR; Tan CP; Ji LN; Mao ZW Sci Rep; 2016 Dec; 6():38954. PubMed ID: 27958338 [TBL] [Abstract][Full Text] [Related]
14. Brominated cyclometalated iridium(III) complexes for mitochondrial immobilization as potential anticancer agents. Liu B; Chen Z; Li Y; Du XF; Zhang W; Zhang W; Lai Y; Li Y Dalton Trans; 2022 May; 51(19):7650-7657. PubMed ID: 35510904 [TBL] [Abstract][Full Text] [Related]
15. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents. Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052 [TBL] [Abstract][Full Text] [Related]
16. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents. Song XD; Kong X; He SF; Chen JX; Sun J; Chen BB; Zhao JW; Mao ZW Eur J Med Chem; 2017 Sep; 138():246-254. PubMed ID: 28668477 [TBL] [Abstract][Full Text] [Related]
17. Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents. Li Y; Tan CP; Zhang W; He L; Ji LN; Mao ZW Biomaterials; 2015 Jan; 39():95-104. PubMed ID: 25477176 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, photophysical and anticancer properties of mitochondria-targeted phosphorescent cyclometalated iridium(III) N-heterocyclic carbene complexes. Li Y; Wang KN; He L; Ji LN; Mao ZW J Inorg Biochem; 2020 Apr; 205():110976. PubMed ID: 31926377 [TBL] [Abstract][Full Text] [Related]
19. Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents. Peng W; Hegazy AM; Jiang N; Chen X; Qi HX; Zhao XD; Pu J; Ye RR; Li RT J Inorg Biochem; 2020 Feb; 203():110909. PubMed ID: 31689591 [TBL] [Abstract][Full Text] [Related]
20. Near-infrared phosphorescent cyclometalated platinum (II) and iridium (III) complexes with metformin moiety: Design and study towards anticancer theranostic agents. Yang J; Wang WT; Shi ZD; Yang R; Liao XL; Yang B; Gao CZ J Inorg Biochem; 2022 Dec; 237():111992. PubMed ID: 36126432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]